Lincoln Pharmaceuticals, engaged in manufacturing pharma products like Tablets, Capsules, Injectable, Syrups, Ointments, etc. at its state of art, fully automated, ultramodern, WHO-GMP standards and 150-9001 certified manufacturing activities near Ahmedabad.

Lincoln Pharma has excellent in house fully automated R&D set up, Certified by Science and Technology Department of Government of India, Delhi. One new MILESTONE created by R&D team of Scientists has developed a new Novel Drug Delivery System (NDDS) Micronized Progesterone Vaginal Spray. The brand of Micronized Progesterone Vaginal Spray is ART-Luton.

Progesterone is essential for the development of decidual tissue and the effect of progesterone on the differentiation of glandular epithelia and stroma has been extensively studied. Progesterone administration decreases the circulatory levels of gonadotropins.

Progesterone is lipophilic in nature and diffuses freely into cells, where it binds to the Progesterone receptors and exerts presentational activity.

ART-Luton is indicated for the treatment of Luteal Phase Support in ART, dysmenorrhoea, premenstrual syndrome etc. Micronized Progesterone Vaginal Spray is now launched in FIRST TIME IN INDIA the Company has a presence in PAN India. With the 'lunch of this new product, the revenues and profitability of Lincoln will go up.

Shares of the company gained Rs 10.4, or 4.37%, to trade at  Rs 248.50.  The total volume of shares traded  was  257,477 at the BSE (11.31 a.m., Friday).